HCAL
CORT icon

HURRICANE CAPITAL ADVISORS LLC’s Corcept Therapeutics CORT Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6K Buy
+364
New +$22K 0.01% 595
2026
Q1 		– Sell
-1,101
Closed -$38.3K – 751
2025
Q4 		$38.3K Buy
1,101
+231
+27% +$18.1K 0.01% 572
2025
Q3 		$72.3K Hold
870
– – 0.02% 481
2025
Q2 		$63.9K Buy
+870
New +$63.1K 0.02% 430

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ingalls & Snyder LLC
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's CORT Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 364 shares worth $31.6K. The stake represents 0.01% of the portfolio and ranks #595 among its holdings. This is a return to the name: HURRICANE CAPITAL ADVISORS LLC previously reported a position in CORT as recently as Q4 2025.

HURRICANE CAPITAL ADVISORS LLC first reported a position in CORT in Q2 2025 and has held it in 4 quarters since. The position peaked at $72.3K in Q3 2025. 424 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 364 shares of Corcept Therapeutics worth $31.6K as of Q2 2026.
  • Corcept Therapeutics was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #595 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's Corcept Therapeutics position peaked at $72.3K in Q3 2025.
  • 424 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.